Hear from us 29 November 2023 Orphelia Pharma secures US patent covering KIZFIZO®, first drinkable formulation of temozolomide Read More > 28 November 2023 ORPHELIA Pharma to support the European paediatric Soft Tissue Sarcoma Study Group winter meeting. Read More > 2 November 2023 Medicines for Europe : 5th Value Added Medicines Conference, 7th November 2023, Brussels Read More > 30 October 2023 Event : BioEurope Fall 2023 (November 6-8, 2023; Munich, Germany) Read More > 24 October 2023 Orphelia Pharma dépose une demande d’autorisation de mise sur le marché en Europe pour KIZFIZO® Read More > 24 October 2023 Orphelia Pharma files EU marketing authorization application for KIZFIZO® Read More >